Top 5 Life Science VC Funds in Hong Kong
A list of 5 VC funds that invest in Life science startups based in Hong kong. We rank investors based on the number of investments they made in Life science companies from Hong kong. We update this investor list every month.Top 5 Life Science VC Funds in Hong Kong
Investor | Life Science Hong Kong investments |
---|---|
Proxima Ventures Ltd | 1 |
Prox Ventures | 1 |
Hillhouse Investment | 1 |
Vectr | 1 |
Tiger Jade Capital | 1 |
Proxima Ventures is focused on the management of investment portfolios for its customers. It offers them with financial products and consulting services.
Proxima Ventures was acquired by Soluto in October 2013.
Proxima Ventures was founded by Chaim Venezia and Uri Ra'anan and is based in Tel Aviv, Israel.
Show more
Investment focus
- Biotechnology, Health Care, Health Diagnostics
- Series A, Series B, Seed
- China, United States, Israel
Portfolio highlights
- VerImmune — Located in Baltimore, Maryland, VerImmune is an Immuno-Oncology company developing a first-in-class cancer therapy known as Anti-tumor Immune Redirection. This strategy utilizes a proprietary tumor-specific, tumor type agnostic, virus-inspired platform termed Anti-tumor Immune Redirection Virus-inspired Particles (AIR-ViPs) that redirectspre-existing pathogenic or childhood vaccine immune memory towards tumors.
- Yidianling — Yidianling is a psychological counselling platform that provides free mental health services such as free questions and answers, psychological tests, expert services, and training lectures.
- Great Bay Bio — Great Bay Bio Ltd. is a high-tech company that develops blue ocean biopharmaceuticals with a digital platform. It has a long history of biomedical research and development and rich experience in product development. Adhering to the national strategic concept of scientific and technological innovation and coordinated development of the Greater BayArea, Dawan Biotechnology brings together high-quality resources from Europe, the United States, Singapore, and Hong Kong to build a biopharmaceutical development platform centered on AI technology, big data, and Internet of Things technology, which greatly shortens The drug development cycle significantly reduces development costs and has great industry competitive advantages.
Proxima Ventures focuses in the healthcare industry, supporting outstanding enterprises with innovative technologies or service models that have tremendous potential.They manage multiple funds in RMB and US dollar, covering from seed to growth stages. Their team members with multidisciplinary backgrounds and resourceful networks, have many yearsof remarkable venture capital experience and achievements. They believe that active and effective collaboration with entrepreneurs will make substantial economic returns while bring meaningful improvements in public health.
Show more
Investment focus
- Medical, Biotechnology, Health Care
- Funding Round, Seed, Series A
- China, United States, United Kingdom
Portfolio highlights
- VerImmune — Located in Baltimore, Maryland, VerImmune is an Immuno-Oncology company developing a first-in-class cancer therapy known as Anti-tumor Immune Redirection. This strategy utilizes a proprietary tumor-specific, tumor type agnostic, virus-inspired platform termed Anti-tumor Immune Redirection Virus-inspired Particles (AIR-ViPs) that redirectspre-existing pathogenic or childhood vaccine immune memory towards tumors.
- Zhenyi Yiliao — Zhenyi Yiliao is a medical enterprise focusing on structural heart disease.
- Rhino Medical — Rhino Medical develops advanced technologies with independent intellectual property rights. The founding team has rich experience in R&D, marketing, and clinical. On the basis of benchmarking imported phacoemulsification instruments and vitrectomy instruments
Hillhouse Capital Group is an investment management firm that invests with a long-term time horizon. Hillhouse owns companies across equity stages, spanning the range from new start-ups to the world’s most established public companies. It may invest in a company as a start-up and continue to hold it in the portfolio as a public equity investment.This stage-agnostic investment style allows them to focus on multi-year results, rather than on quarterly earnings.Hillhouse Capital Group invests globally, with a particular focus on Asia. Independent, proprietary research lies at the heart of our investment process. Our team members are sector experts in consumer, Internet, media, and healthcare. Hillhouse Capital Group was founded in 2005 and is based in Beijing, China.
Show more
Investment focus
- Biotechnology, Health Care, Software
- Series B, Series A, Series C
- China, United States, India
Portfolio highlights
- Tenways — TENWAYS Electric Bikes with multi-scenario applications for superior value, light weight, quick charge and instant assistance. For commuting, lifestyle, exercising and more.
- Xingmai Innovation — Xingmai Innovation creates, develops, and sells intelligent swimming pool cleaning robots.
- Deep Vision Intelligence — Deep Vision Intelligence is a developer of embedded machine vision products.
Vectr is a venture firm based in Hong Kong. They combine investment, creation and growth to deliver game-changing impact to teams ready to tackle global issues, transform industries and improve the lives of millions.That combines capital, creation and partnership to deliver game-changing impact. We strive to be the ideal partner for founders thatare building transformation products and looking to expand their businesses into asia.
Show more
Investment focus
- FinTech, Financial Services, Artificial Intelligence
- Seed, Series A, Pre-Seed
- United States, Hong Kong, Singapore
Portfolio highlights
- Percent — Unlock private credit investments with Percent. Access alternative investments on the platform powering the future of private markets.
- Micro Connect — Micro Connect provides market infrastructure, fintech, and platform development.
- MasterExchange — Trading platform for music rights leveraging emerging technology to create friction free and compliant investment opportunities to everyone.
Tiger Jade Capital is a Private Equity fund focused on global healthcare industry. It is a comprehensive healthcare fund covering new drugs, CRO, medical equipment, etc.
Show more
Investment focus
- Biopharma, Life Science, Biotechnology
- Series A
- Hong Kong
Portfolio highlights
- Great Bay Bio — Great Bay Bio Ltd. is a high-tech company that develops blue ocean biopharmaceuticals with a digital platform. It has a long history of biomedical research and development and rich experience in product development. Adhering to the national strategic concept of scientific and technological innovation and coordinated development of the Greater BayArea, Dawan Biotechnology brings together high-quality resources from Europe, the United States, Singapore, and Hong Kong to build a biopharmaceutical development platform centered on AI technology, big data, and Internet of Things technology, which greatly shortens The drug development cycle significantly reduces development costs and has great industry competitive advantages.
Investors by industry
Health Care
Biotech
Community
Marketplace
FinTech
Impact
Proptech
Media (entertainment)
EdTech
Consumer
Climate
Energy
Hardware
Gaming
Artificial intelligence
Venture Capital
Sustainability
Agriculture (agtech)
Publishing
Beauty
Oil and Gas
Web3
Video Games
Food and Beverage
Clean Energy
Real Estate
Infrastructure
Big Data
Organic Food
Photography
Fashion
Education
B2B
Renewable Energy
Payments
Financial Services
Sporting Goods
Finance
Retail
Medical
Email
Wellness
Social Media
Music
Franchise
Celebrity
Android
Internet
Legal
Google
eSports
Construction
Local
Mobile
Enterprise Software
Sports
Social Network
Manufacturing
Digital Media
Facebook
Art
Social Impact
Recruiting
Platforms
Travel
Fitness
Mobile Advertising
Cannabis
Biotechnology
Hospitality
Automotive
Crowdfunding
Wine And Spirits
Medical Device
Social
CleanTech
Transportation
Mobile Apps
InsurTech
Restaurants
Enterprise
SaaS
LGBT
Film
Life Science
Theatre
Non Profit
Cryptocurrency
Software
Blockchain
Investors by country
Canada
United Kingdom
Ireland
Germany
South Korea
Australia
United States
India
New Zealand
Oceania
Armenia
China
Europe
Indonesia
LATAM
Middle East
Spain
Asia
Japan
South Africa
Qatar
Vietnam
Saudi Arabia
Singapore
Sri Lanka
Brazil
Africa
Czech Republic
Bahrain
Belize
Bermuda
Costa Rica
Belarus
Bulgaria
Denmark
Algeria
Georgia
Gibraltar
Cameroon
Kuwait
Israel
Chile
Jersey
Kazakhstan
Nicaragua
Philippines
Finland
Italy
Estonia
Mali
Lithuania
Cambodia
Faroe Islands
Liechtenstein
Greece
Kenya
Liberia
Ethiopia
Lebanon
Mauritius
Morocco
Ghana
Malaysia
Norway
Peru
Hungary
Myanmar
Cayman Islands
Panama
Croatia
Malta
Mexico
Egypt
Seychelles
Slovenia
Belgium
Russian Federation
Barbados
Ecuador
Rwanda
France
Serbia
Uzbekistan
Hong Kong
Togo
Taiwan
Nigeria
Ukraine
Sierra Leone
Turkey
Tunisia
Thailand
Tajikistan
Poland
Uganda
Zimbabwe
Tanzania
San Marino
Uruguay
Venezuela
Zambia
Bahamas
Senegal
Puerto Rico
Azerbaijan
Iraq
Portugal
Iceland
Sweden
El Salvador
Namibia
Honduras
United Arab Emirates
Isle of Man
Luxembourg
Bolivia
Argentina
Pakistan
Albania
Austria
Bangladesh
Grenada
Jordan
Romania
Cyprus
Latvia
Oman
Colombia
Switzerland
Guatemala
Marshall Islands
VC Funds in Hong Kong by industry
Social
Financial Services
Big Data
Cryptocurrency
Education
Finance
Payments
Food and Beverage
Organic Food
Medical
Wellness
Agriculture (agtech)
Internet
Social Media
Manufacturing
Art
Digital Media
Music
Mobile
Blockchain
Construction
Software
Sports
eSports
Hospitality
Travel
InsurTech
Recruiting
Biotechnology
Enterprise
FinTech
Biotech
Health Care
EdTech
Energy
Climate
Sustainability
Proptech
SaaS
Marketplace
Artificial intelligence
Community
Hardware
Gaming
Real Estate
Mobile Apps
Retail
Fashion
Web3
Life Science
B2B
Enterprise Software
Consumer
Transportation
Clean Energy
Media (entertainment)
Video Games
Fitness
Impact